Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice Guideline von Yarom, Noam, Shapiro, Charles L, Peterson, Douglas E, Van Poznak, Catherine H, Bohlke, Kari, Ruggiero, Salvatore L, Migliorati, Cesar A, Khan, Aliya, Morrison, Archie, Anderson, Holly, Murphy, Barbara A, Alston-Johnson, Devena, Mendes, Rui Amaral, Beadle, Beth Michelle, Jensen, Siri Beier, Saunders, Deborah P

Volltext

Treatment of Hypercalcemia of Malignancy in Adults: An Endocrine Society Clinical Practice Guideline von El-Hajj Fuleihan, Ghada, Clines, Gregory A, Hu, Mimi I, Marcocci, Claudio, Murad, M Hassan, Piggott, Thomas, Van Poznak, Catherine, Wu, Joy Y, Drake, Matthew T

Volltext

Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: A Cancer Care Ontario and American Society of Clinical Oncology Clinical Practice Guideline von Dhesy-Thind, Sukhbinder, Fletcher, Glenn G, Blanchette, Phillip S, Clemons, Mark J, Dillmon, Melissa S, Frank, Elizabeth S, Gandhi, Sonal, Gupta, Rasna, Mates, Mihaela, Moy, Beverly, Vandenberg, Ted, Van Poznak, Catherine H

Volltext

Paclitaxel Plasma Concentration after the First Infusion Predicts Treatment-Limiting Peripheral Neuropathy von Hertz, Daniel L, Kidwell, Kelley M, Vangipuram, Kiran, Li, Feng, Pai, Manjunath P, Burness, Monika, Griggs, Jennifer J, Schott, Anne F, Van Poznak, Catherine, Hayes, Daniel F, Lavoie Smith, Ellen M, Henry, N Lynn

Volltext

Activating ESR1 mutations in hormone-resistant metastatic breast cancer von Robinson, Dan R, Wu, Yi-Mi, Vats, Pankaj, Su, Fengyun, Lonigro, Robert J, Cao, Xuhong, Kalyana-Sundaram, Shanker, Wang, Rui, Ning, Yu, Hodges, Lynda, Gursky, Amy, Siddiqui, Javed, Tomlins, Scott A, Roychowdhury, Sameek, Pienta, Kenneth J, Kim, Scott Y, Roberts, J Scott, Rae, James M, Van Poznak, Catherine H, Hayes, Daniel F, Chugh, Rashmi, Kunju, Lakshmi P, Talpaz, Moshe, Schott, Anne F, Chinnaiyan, Arul M

Volltext

Bisphosphonate‐Associated Osteonecrosis of the Jaw: Report of a Task Force of the American Society for Bone and Mineral Research von Khosla, Sundeep, Burr, David, Cauley, Jane, Dempster, David W, Ebeling, Peter R, Felsenberg, Dieter, Gagel, Robert F, Gilsanz, Vincente, Guise, Theresa, Koka, Sreenivas, McCauley, Laurie K, McGowan, Joan, McKee, Marc D, Mohla, Suresh, Pendrys, David G, Raisz, Lawrence G, Ruggiero, Salvatore L, Shafer, David M, Shum, Lillian, Silverman, Stuart L, Van Poznak, Catherine H, Watts, Nelson, Woo, Sook‐Bin, Shane, Elizabeth

Volltext

American Society of Clinical Oncology Executive Summary of the Clinical Practice Guideline Update on the Role of Bone-Modifying Agents in Metastatic Breast Cancer von VAN POZNAK, Catherine H, TEMIN, Sarah, ZUCKERMAN, Dan S, VON ROENN, Jamie H, YEE, Gary C, JANJAN, Nora A, BARLOW, William E, BIERMANN, J. Sybil, BOSSERMAN, Linda D, GEOGHEGAN, Cindy, HILLNER, Bruce E, THERIAULT, Richard L

Volltext

Patients carrying CYP2C83 have shorter systemic paclitaxel exposure von Marcath, Lauren A, Kidwell, Kelley M, Robinson, Adam C, Vangipuram, Kiran, Burness, Monika L, Griggs, Jennifer J, Poznak, Catherine Van, Schott, Anne F, Hayes, Daniel F, Henry, Norah Lynn, Hertz, Daniel L

Volltext

Significance of Circulating Tumor Cells in Metastatic Triple-Negative Breast Cancer Patients within a Randomized, Phase II Trial: TBCRC 019 von Paoletti, Costanza, Li, Yufeng, Muñiz, Maria C, Kidwell, Kelley M, Aung, Kimberly, Thomas, Dafydd G, Brown, Martha E, Abramson, Vandana G, Irvin, Jr, William J, Lin, Nancy U, Liu, Minetta C, Nanda, Rita, Nangia, Julie R, Storniolo, Anna M, Traina, Tiffany A, Vaklavas, Christos, Van Poznak, Catherine H, Wolff, Antonio C, Forero-Torres, Andres, Hayes, Daniel F

Volltext

Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideli... von Krop, Ian, Ismaila, Nofisat, Andre, Fabrice, Bast, Robert C, Barlow, William, Collyar, Deborah E, Hammond, M Elizabeth, Kuderer, Nicole M, Liu, Minetta C, Mennel, Robert G, Van Poznak, Catherine, Wolff, Antonio C, Stearns, Vered

Volltext

TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases von Freedman, Rachel A, Gelman, Rebecca S, Anders, Carey K, Melisko, Michelle E, Parsons, Heather A, Cropp, Anne M, Silvestri, Kelly, Cotter, Christine M, Componeschi, Kathryn P, Marte, Juan M, Connolly, Roisin M, Moy, Beverly, Van Poznak, Catherine H, Blackwell, Kimberly L, Puhalla, Shannon L, Jankowitz, Rachel C, Smith, Karen L, Ibrahim, Nuhad, Moynihan, Timothy J, O'Sullivan, Ciara C, Nangia, Julie, Niravath, Polly, Tung, Nadine, Pohlmann, Paula R, Burns, Robyn, Rimawi, Mothaffar F, Krop, Ian E, Wolff, Antonio C, Winer, Eric P, Lin, Nancy U

Volltext

Management of Male Breast Cancer: ASCO Guideline von Hassett, Michael J, Somerfield, Mark R, Baker, Elisha R, Cardoso, Fatima, Kansal, Kari J, Kwait, Dylan C, Plichta, Jennifer K, Ricker, Charité, Roshal, Anna, Ruddy, Kathryn J, Safer, Joshua D, Van Poznak, Catherine, Yung, Rachel L, Giordano, Sharon H

Volltext

Associations between genetic variants and the effect of letrozole and exemestane on bone mass and bone turnover von Oesterreich, Steffi, Henry, N. Lynn, Kidwell, Kelley M., Van Poznak, Catherine H., Skaar, Todd C., Dantzer, Jessica, Li, Lang, Hangartner, Thomas N., Peacock, Munro, Nguyen, Anne T., Rae, James M., Desta, Zeruesenay, Philips, Santosh, Storniolo, Anna M., Stearns, Vered, Hayes, Daniel F., Flockhart, David A.

Volltext

Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: ASCO-OH (CCO) Guideline Update von Eisen, Andrea, Somerfield, Mark R, Accordino, Melissa K, Blanchette, Phillip S, Clemons, Mark J, Dhesy-Thind, Sukhbinder, Dillmon, Melissa S, D'Oronzo, Stella, Fletcher, Glenn G, Frank, Elizabeth S, Hallmeyer, Sigrun, Makhoul, Issam, Moy, Beverly, Thawer, Alia, Wu, Joy Y, Van Poznak, Catherine H

Volltext

A prospective study of aromatase inhibitor‐associated musculoskeletal symptoms and abnormalities on serial high‐resolution wrist ultrasonography von Henry, N. Lynn, Jacobson, Jon A., Banerjee, Mousumi, Hayden, Jill, Smerage, Jeffrey B., Van Poznak, Catherine, Storniolo, Anna Maria, Stearns, Vered, Hayes, Daniel F.

Volltext

MASCC/ISOO Clinical Practice Statement: Adjuvant bone-modifying agents in primary breast cancer patients - prevention of medication-related osteonecrosis of the jaw von Yarom, Noam, Van Poznak, Catherine H., Epstein, Joel B., Ottaviani, Giulia, Matsuda, Yuhei, Migliorati, Cesar, Elad, Sharon

Volltext

Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology-Cancer Care Ontario Focused Guideline Update von Van Poznak, Catherine, Somerfield, Mark R, Barlow, William E, Biermann, J Sybil, Bosserman, Linda D, Clemons, Mark J, Dhesy-Thind, Sukhbinder K, Dillmon, Melissa S, Eisen, Andrea, Frank, Elizabeth S, Jagsi, Reshma, Jimenez, Rachel, Theriault, Richard L, Vandenberg, Theodore A, Yee, Gary C, Moy, Beverly

Volltext

Oncotype Dx Results in Multiple Primary Breast Cancers von Toole, Michael J., Kidwell, Kelley M., Van Poznak, Catherine

Volltext

ADAMTS1 and MMP1 proteolytically engage EGF-like ligands in an osteolytic signaling cascade for bone metastasis von Lu, Xin, Wang, Qiongqing, Hu, Guohong, Van Poznak, Catherine, Fleisher, Martin, Reiss, Michael, Massagué, Joan, Kang, Yibin

Volltext

Phase III Randomized Trial of Bisphosphonates as Adjuvant Therapy in Breast Cancer: S0307 von Gralow, Julie R, Barlow, William E, Paterson, Alexander H G, M'iao, Jieling L, Lew, Danika L, Stopeck, Alison T, Hayes, Daniel F, Hershman, Dawn L, Schubert, Mark M, Clemons, Mark, Van Poznak, Catherine H, Dees, Elizabeth C, Ingle, James N, Falkson, Carla I, Elias, Anthony D, Messino, Michael J, Margolis, Jeffrey H, Dakhil, Shaker R, Chew, Helen K, Dammann, Kim Z, Abrams, Jeffrey S, Livingston, Robert B, Hortobagyi, Gabriel N

Volltext